Transparency Guideline for the Relation between Corporate Activities and Medical Institutions Q&A
About Purpose
- Q1 Why are Transparency Guidelines necessary?
- Q2 What is the purpose of the newspaper advertisement "What is the money paid by JPMA to hospitals and doctors? What is the purpose of the ad? And what do you want to convey?
About information disclosure
- Q3 What kind of fees do pharmaceutical companies pay to medical institutions and physicians?
- Q4 How can I view publicly available information?
- Q5 Why does the method of disclosure differ from company to company?
- Q6 How long has the information been available to the public? Can I view the information retroactively?
About implementing companies and their enforceability
- Q7 Do all JPMA member pharmaceutical companies formulate and publish Transparency Guideline?
- Q8 Are the Transparency Guidelines enforceable and are there penalties for violations?
Donations
Impact on Patients, Consumers, and Medical Professionals
- Q10. How do the disclosed amounts paid to medical institutions and medical professionals affect the price of drugs?
- Q11. Are there any cases in which publicly disclosed information falls under the category of personal information?
- Q12 Is there any possibility that the payment of money by pharmaceutical companies to healthcare professionals may distort the activities and judgment of healthcare professionals?
About overseas cases
About each item subject to disclosure
- Q14 What are the research and development expenses, etc.?
- Q15 What is a scholarship donation?
- Q16 What are donations from academic societies?
- Q17 What are honoraria for lectures, fees for writing and supervising manuscripts, and fees for outsourcing consulting and other services?
- Q18 What are lecture meeting fees?
- Q19 What are "other expenses"?